Related Experiment Videos
Transferrin receptor in oral tumors
T Miyamoto1, N Tanaka, Y Eishi
1First Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Tokyo Medical and Dental University, Japan.
International Journal of Oral and Maxillofacial Surgery
|December 1, 1994
Summary
Transferrin receptor (TfR) expression is elevated in oral cancers, particularly in those with poor prognoses. TfR levels decrease with reduced cancer cell proliferation, suggesting its potential as a prognostic marker.
Area of Science:
- Oncology
- Cell Biology
- Immunohistochemistry
Background:
- The transferrin receptor (TfR) is crucial for cell proliferation.
- TfR expression is observed in rapidly dividing cells.
Purpose of the Study:
- To investigate TfR expression in oral tissues using immunohistochemistry.
- To quantitatively analyze TfR in a cancer cell line after anticancer drug treatment via flow cytometry.
- To evaluate TfR as a potential prognostic marker in oral cancer.
Main Methods:
- Immunohistochemical staining of TfR in oral tissue samples.
- Quantitative flow cytometry analysis of TfR expression in cancer cell lines.
- Correlation analysis between TfR expression and tumor prognostic factors.
Main Results:
- TfR was detected in the parabasal and basal layers of normal oral epithelium.
- Benign oral tumors showed rare TfR expression.
- Malignant oral tumors, especially those with poor prognoses, exhibited strong TfR staining irrespective of differentiation.
- Flow cytometry revealed decreased TfR amounts correlating with reduced cancer cell proliferation.
Conclusions:
- TfR expression is associated with oral malignancy and poor prognosis.
- TfR levels decrease as cancer cell proliferative ability diminishes.
- TfR may serve as a valuable prognostic marker for oral cancer.